openPR Logo
Press release

Global dyslipidemia market is expected to rise gradually to an estimated value of USD 27.52 billion by 2026: A Report By AstraZeneca (UK), Merck, Pfizer, Sanofi, Alnylam Pharmaceuticals, Amarin Corporation, Amgen, Bristol-Myers Squibb, Catabasis Pharmaceu

06-20-2019 12:37 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global dyslipidemia market is expected to rise gradually to

Dyslipidemia is a condition in which the levels of lipids (cholesterol, triglycerides, or both) or low high-density lipoprotein (HDL) cholesterol level elevated due to multiple reasons including lifestyle, genetics-disorders, drugs etc.
According to World Health Organization, there were approximately 17.9 million people in 2016, who died from cardiovascular diseases, almost more than half of these cases could have been avoided with the availability of proper medical treatment. This significant number is expected to act as a driver to the market growth.

Market Analysis:
Global dyslipidemia market is expected to rise gradually to an estimated value of USD 27.52 billion by 2026, registering a CAGR of 10.50% in the forecast period of 2019-2026 with the annual sales of USD 12.38 billion in the year of 2018. This rise in market value can be attributed to the increase in prevalence and awareness along with concerns regarding the health of patients.

Download Sample PDF Report https://databridgemarketresearch.com/request-a-sample/?dbmr=global-dyslipidemia-market

Key Market Competitors: Global Dyslipidemia Market
Few of the major competitors currently working in the Dyslipidemia market are
• AstraZeneca (UK)
• Merck, Pfizer
• Sanofi
• Alnylam Pharmaceuticals
• Amarin Corporation
• Amgen
• Bristol-Myers Squibb
• Catabasis Pharmaceuticals
• Cerenis
• Cipla Inc.
• CJ HealthCare
• CKD Bio
• Daewoong Pharmaceutical
• Daiichi Sankyo
• Eli Lilly
• Esperion Therapeutics
• GlaxoSmithKline
• JW Pharmaceuticals
• Kadmon Pharmaceuticals
• Lupin Pharmaceuticals and few among others

Key Developments in the Market:
• In the year 2018, Sanofi and Regeneron Pharmaceuticals, Inc. announced that Praluent (alirocumab) in phase 3 clinical trialdemonstrated the risk of major adverse cardiovascular events (MACE) in patients who had suffered a recent acute coronary syndrome (ACS) event such as a heart attack.
• In the year 2018, Amgen Inc. announced the launch of Repatha (Evolocumab) in the US for the indication of heart attacks and stroke due to high cholesterol at a reduced price to gain more customers.
• In the year 2015, WuXi PharmaTech announced its partnership with Eli Lilly to develop, manufacture, and commercializes in China a Lilly-discovered oral experimental drug for cardiovascular risk in patients with dyslipidemia.

Get Detailed TOC https://databridgemarketresearch.com/toc/?dbmr=global-dyslipidemia-market

Market Drivers
• Increase in global geriatric population
• Increase in prevalence of lifestyle diseases
• Rise in acceptance of telemental health
• Increase in availability of generic drugs

Market Restraints
• Lack of R&D initiatives in this area.
• patent expiry for some blockbuster drugs
• Fewer Government initiatives taken in this direction.

Segmentation: Global Dyslipidemia Market
By Product type
• Statin Drugs
o High-intensity
o Moderate-intensity
o Low-intensity

Non-Statin Lipid–Lowering Drugs
• Bile Acid Sequestrants
• Cholestyramine
• Colesevelam
• Cholybar
• Colestipol
• Cholesterol Absorption Inhibitor
• Fibrates
• Nicotinic Acid
• PCSK9 Monoclonal Antibodies
• omega-3 Fatty Acids
• Combination Products

By Types
• Primary dyslipidemia
• Secondary dyslipidemia

By Distribution Channel
• Hospitals Pharmacies
• Drug Store
• Online Pharmacies
• Retail Pharmacies

By End- User
• Hospital and Clinics
• Medical laboratories
• Others

Competitive Analysis: Global dyslipidemia market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of dyslipidemia market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Speak to Author https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-dyslipidemia-market

Data Bridge Market Research
Office Number 402, Amanora Chambers,
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India
Email: sopan.gedam@databridgemarketresearch.com

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global dyslipidemia market is expected to rise gradually to an estimated value of USD 27.52 billion by 2026: A Report By AstraZeneca (UK), Merck, Pfizer, Sanofi, Alnylam Pharmaceuticals, Amarin Corporation, Amgen, Bristol-Myers Squibb, Catabasis Pharmaceu here

News-ID: 1782479 • Views: 123

More Releases from Data Bridge Market Research

Tissue Regeneration Market Forecast Analysis by 2026| Cook, CryoLife, Inc., Cyto …
Global tissue regeneration market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of tissue regeneration market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa. The market insights gained through this Tissue Regeneration Market research analysis report facilitates more
Tinnitus Drug Market to 2026: Key Players Mylan N.V., Sun Pharmaceutical Industr …
Global Tinnitus Drug Market By Type (Subjective Tinnitus, Neurological Tinnitus, Somatic Tinnitus, Objective Tinnitus), Therapy Type (Cognitive Behavioral Therapy, Tinnitus Retraining Therapy), Treatment Type (Medication and Surgery), Drug Class Type (Antidepressant Drugs, Antianxiety Drugs), Route of Administration (Oral and Injectable), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026 Global Tinnitus Drug Market is expected
Global customer success platforms market To Gain Tremendous Growth | Gainsight, …
Customer success platforms market research report comprises of several parameters which are thoroughly studied by the experts. Market research analysis and data lend a hand to businesses for the planning of production, product launches, costing, inventory, purchasing and marketing strategies. This market study considers a market attractiveness analysis, where each segment is benchmarked based on its market size, growth rate, and general attractiveness. Market info can be explained more specifically
Global autonomous forklifts market To Witness Rapid Economic Growth | Toyota Ind …
This global Autonomous Forklifts market research report offers you an array of insights about ICT industry and business solutions that will support to stay ahead of the competition. Systematic investment analysis is also underlined in this Autonomous Forklifts report which forecasts impending opportunities for the market players. This market report is the outcome of persistent efforts lead by knowledgeable forecasters, innovative analysts and brilliant researchers who carries out detailed and

All 5 Releases


More Releases for Pharmaceutical

Metronidazole Market by Top Manufacturers – Hongyuan Pharmaceutical, Yinhe Aar …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market by Top Manufacturers – Hongyuan Pharmaceutical, Yinhe Aar …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR Scope of the Report: This report focuses on the Metronidazole in global market, especially in
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil Scope of the Report: This report focuses on the Metronidazole in global market, especially in North
Evolving Pharmaceutical Marketing Strategies
Publisher’s latest report,"Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing" provides a comprehensive analysis of the changing pharmaceutical marketing landscape in the digital age. While the pharmaceutical industry readily adopts new technologies to provide medical advancements, it has been much slower to adopt technology within its marketing efforts, mostly relying on traditional channels and methods. However, the decreasing effectiveness of these traditional channels, given changing physician, patient
Vitamin C Market 2017 -CSPC Pharmaceutical Group, DSM, Shandong Luwei Pharmaceut …
Apex Research, recently published a detailed market research study focused on the "Vitamin C Market" across the global, regional and country level. The report provides 360° analysis of "Vitamin C Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Vitamin C industry, and estimates the future trend of Vitamin C market